Wikipedia:Version 1.0 Editorial Team/Pharmacology articles by quality log
Appearance
This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record. |
September 21, 2024
[edit]Reassessed
[edit]- Arimoclomol (talk) reassessed. Importance rating changed from Low-Class to Mid-Class. (rev · t)
Assessed
[edit]- TP0586532 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
September 20, 2024
[edit]Assessed
[edit]- Iboxamycin (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Monkey Drug Trials (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
September 19, 2024
[edit]Renamed
[edit]- Draft:(S)-MK-26 renamed to (S)-MK-26.
- Draft:CE-158 renamed to CE-158.
- Draft:JJC8-016 renamed to JJC8-016.
- Draft:UB-311 renamed to UB-311.
Assessed
[edit]- Advil (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Afabicin (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- BMS-986187 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Ganfeborole (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Ignavine (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- LPC-233 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- List of modafinil analogues and derivatives (talk) assessed. Quality assessed as List-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- MS1 (drug) (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Pro-motivational agent (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Pseudouridimycin (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- SPR741 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
September 17, 2024
[edit]Reassessed
[edit]- 5,6-Dihydroxytryptamine (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)
- Galactose-α-1,3-galactose (talk) reassessed. Quality rating changed from Redirect-Class to Start-Class. (rev · t)
- Xylamine (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
- Α,N-DMT (talk) reassessed. Quality rating changed from Redirect-Class to Stub-Class. (rev · t)
- Α-Pyrrolidinobutiophenone (talk) reassessed. Quality rating changed from Redirect-Class to Stub-Class. (rev · t) Importance rating changed from NA-Class to Unknown-Class. (rev · t)
- Β-Fuoxymorphamine (talk) reassessed. Quality rating changed from Redirect-Class to Stub-Class. (rev · t)
- Γ-Hydroxybutyric acid (talk) reassessed. Quality rating changed from Redirect-Class to B-Class. (rev · t)
Assessed
[edit]- Draft:(S)-MK-26 (talk) assessed. Importance assessed as NA-Class. (rev · t)
- Draft:CE-158 (talk) assessed. Importance assessed as NA-Class. (rev · t)
- CT-005404 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Draft:JJC8-016 (talk) assessed. Importance assessed as NA-Class. (rev · t)
- Legality of cannabis (talk) assessed. Quality assessed as List-Class. (rev · t) Importance assessed as Top-Class. (rev · t)
- Tobacco industry (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as High-Class. (rev · t)
- Draft:UB-311 (talk) assessed. Importance assessed as NA-Class. (rev · t)
September 16, 2024
[edit]Renamed
[edit]- 11-Hydroxy-Delta-8-THC renamed to 11-Hydroxy-Δ-8-THC.
- Alpha,N,O-TMS renamed to Α,N,O-TMS.
- Alpha,N-DMT renamed to Α,N-DMT.
- Alpha-D2PV renamed to Α-D2PV.
- Alpha-Melanocyte-stimulating hormone renamed to Α-Melanocyte-stimulating hormone.
- Alpha-Pyrrolidinobutiophenone renamed to Α-Pyrrolidinobutiophenone.
- Alpha-Pyrrolidinohexiophenone renamed to Α-Pyrrolidinohexiophenone.
- Alpha-Pyrrolidinopentiophenone renamed to Α-Pyrrolidinopentiophenone.
- Alpha-Pyrrolidinopentiothiophenone renamed to Α-Pyrrolidinopentiothiophenone.
- Beta-Funaltrexamine renamed to Β-Funaltrexamine.
- Beta-Fuoxymorphamine renamed to Β-Fuoxymorphamine.
- Beta-Melanocyte-stimulating hormone renamed to Β-Melanocyte-stimulating hormone.
- Beta-Methylfentanyl renamed to Β-Methylfentanyl.
- Beta-Phenylmethamphetamine renamed to Β-Phenylmethamphetamine.
- Beta-Sitosterol renamed to Β-Sitosterol.
- Chlornaltrexamine renamed to Β-Chlornaltrexamine.
- Delta-11-Tetrahydrocannabinol renamed to Δ-11-Tetrahydrocannabinol.
- Galactose-alpha-1,3-galactose renamed to Galactose-α-1,3-galactose.
- Gamma-Amino-beta-hydroxybutyric acid renamed to Γ-Amino-β-hydroxybutyric acid.
- Gamma-Hydroxybutyraldehyde renamed to Γ-Hydroxybutyraldehyde.
- Gamma-Hydroxybutyric acid renamed to Γ-Hydroxybutyric acid.
- Gamma-Melanocyte-stimulating hormone renamed to Γ-Melanocyte-stimulating hormone.
- Draft:Gludantan renamed to Gludantan.
- Hydroxy-alpha-sanshool renamed to Hydroxy-α-sanshool.
- Draft:SU-11739 renamed to SU-11739.
Assessed
[edit]- 11-Hydroxy-Δ-8-THC (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- 5,6-Dihydroxytryptamine (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Draft:Aimhub Pharmaceutical Private Limited (talk) assessed. Importance assessed as NA-Class. (rev · t)
- Brensocatib (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Galactose-α-1,3-galactose (talk) assessed. Quality assessed as Redirect-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Hydroxy-α-sanshool (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- SCH-221510 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Xylamine (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Α,N,O-TMS (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Α,N-DMT (talk) assessed. Quality assessed as Redirect-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Α-D2PV (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Α-Melanocyte-stimulating hormone (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Α-Pyrrolidinobutiophenone (talk) assessed. Quality assessed as Redirect-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- Α-Pyrrolidinohexiophenone (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Α-Pyrrolidinopentiophenone (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Α-Pyrrolidinopentiothiophenone (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Β-Chlornaltrexamine (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Β-Funaltrexamine (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Β-Fuoxymorphamine (talk) assessed. Quality assessed as Redirect-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Β-Melanocyte-stimulating hormone (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Β-Methylfentanyl (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Β-Phenylmethamphetamine (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Β-Sitosterol (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Γ-Amino-β-hydroxybutyric acid (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Γ-Hydroxybutyraldehyde (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Γ-Hydroxybutyric acid (talk) assessed. Quality assessed as Redirect-Class. (rev · t) Importance assessed as High-Class. (rev · t)
- Γ-Melanocyte-stimulating hormone (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Δ-11-Tetrahydrocannabinol (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
September 15, 2024
[edit]Renamed
[edit]- Draft:Idramantone renamed to Idramantone.
- Draft:Methoclocinnamox renamed to Methoclocinnamox.
- Draft:Somantadine renamed to Somantadine.
Reassessed
[edit]- Carmantadine (talk) reassessed. Quality rating changed from NA-Class to Stub-Class. (rev · t) Importance rating changed from NA-Class to Unknown-Class. (rev · t)
- Hemantane (talk) reassessed. Quality rating changed from NA-Class to Stub-Class. (rev · t) Importance rating changed from NA-Class to Unknown-Class. (rev · t)
Assessed
[edit]- AGN-1135 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Atezolizumab/hyaluronidase (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
- BMS‐986122 (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Draft:Gludantan (talk) assessed. Importance assessed as NA-Class. (rev · t)
- Naltrexamine (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Draft:SU-11739 (talk) assessed. Importance assessed as NA-Class. (rev · t)
- Tolebrutinib (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)